Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis.
The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intubated patients in emergency situations | Health data will be collected only with medical's record of intubated patients in emergency situation in 2024. | ||
| Intubated patients in non emergency situations | Health data will be collected only with medical's record of intubated patients in non emergency situation in 2024. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Pneumonia rate in 48 hours after the start of orotracheal intubation. | Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation. | Hour 48 |
| Measure | Description | Time Frame |
|---|---|---|
| Pneumonia rate occuring 48 hours after the start of orotracheal intubation. | Rate of pneumonia occuring more than 48 hours after the start of orotracheal intubation. | 3 months |
| Duration of mechanical ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Study population is patient intubated in emergency situation and patients intubated in non-emergency situation following to the admission of intensive care in 2024.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lise Laclautre | Contact | 334.73.754.963 | promo_interne_drci@chu-clermontferrand.fr |
| Name | Affiliation | Role |
|---|---|---|
| Jean-Baptiste BOUILLON-MINOIS | University Hospital, Clermont-Ferrand | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CH Aurillac | Aurillac | 15000 | France |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Duration of mechanical ventilation
| Up to the end of mechanical ventilation (assessed up to 1 month) |
| Duration of stay in intensive care | Duration of stay in intensive care | Up to intensive care discharge (assessed up to 1 month) |
| Duration of hospital stay | Duration of hospital stay | Up to hospital discharge (assessed up to 3 months) |
| Mortality rate | Mortality rate | Inclusion + 1 year |
| Type of bacteria responsible for pneumonia | The bacterial species responsible for pneumonia will be identified using biological samples (blood, urine, bronchial secretions) taken from patients in both groups. The identification of bacterial species will be carried out in the laboratory. | The day of the diagnosis of pneumonia (assessed up to 1 month) |
| Type of antibiotic administered for pneumonia | Type of antibiotic administered for pneumonia in each group | Up to the last day of antibiotic treatment (assessed up to 3 months) |
| Antibiotic doses administered for pneumonia | Comparison of antibiotic doses in g or mg administered in each group | Up to the last day of antibiotic treatment (assessed up to 3 months) |
| Duration of antibiotic treament for pneumonia | Duration of antibiotic treament for pneumonia in each group | Up to the last day of antibiotic treatment (assessed up to 3 months) |
| CHU de Clermont-Ferrand, Clermont-Ferrand | Clermont-Ferrand | France |
|
| CH du Puy en Velay | Le Puy-en-Velay | 43000 | France |
|
| CH de Montluçon | Montluçon | 03100 | France |
|
| CH de Moulins | Moulins | 03000 | France |
|
| CH de Vichy | Vichy | 03200 | France |
|